Why do health technology assessment coverage recommendations for the same drugs differ across settings? : applying a mixed methods framework to systematically compare orphan drug decisions in four European countries
Elena Nicod
| Year of publication: |
July 2017
|
|---|---|
| Authors: | Nicod, Elena |
| Published in: |
The European journal of health economics : HEPAC ; health economics in prevention and care. - Berlin : Springer, ISSN 1618-7598, ZDB-ID 2045253-6. - Vol. 18.2017, 6, p. 715-730
|
| Subject: | Health technology assessment | Orphan drugs | France | England | Scotland | Sweden | Mixed methods research | Thematic analysis | Frankreich | Arzneimittel | Pharmaceuticals | Schweden | Großbritannien | United Kingdom | Gesundheitswesen | Health care system | Technikfolgenabschätzung | Technology assessment | Pharmakologie | Pharmacology | Wissenschaftliche Methode | Scientific method | Pharmaindustrie | Pharmaceutical industry | Vergleich | Comparison | Deutschland | Germany | Bibliometrie | Bibliometrics | Drogenkonsum | Drug consumption |
| Type of publication: | Article |
|---|---|
| Type of publication (narrower categories): | Aufsatz in Zeitschrift ; Article in journal |
| Language: | English |
| Other identifiers: | 10.1007/s10198-016-0823-0 [DOI] |
| Source: | ECONIS - Online Catalogue of the ZBW |
Persistent link: https://www.econbiz.de/10011868947